95 related articles for article (PubMed ID: 25314774)
1. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study].
Kulikov SM; Vinogradova OIu; Chelysheva EIu; Tishchenko IA; Galaĭko MA; Lazareva OV; Senderova OM; Pepeliaeva VM; Meresiĭ SV; Luchinin AS; Ovsepian VA; Miliutina GI; Gavrilova LV; Avdeeva LB; Neverova AL; Turkina AG
Ter Arkh; 2014; 86(7):24-30. PubMed ID: 25314774
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of chronic myeloid leukaemia: an update.
Höglund M; Sandin F; Simonsson B
Ann Hematol; 2015 Apr; 94 Suppl 2():S241-7. PubMed ID: 25814090
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of chronic myeloid leukaemia (CML).
Rohrbacher M; Hasford J
Best Pract Res Clin Haematol; 2009 Sep; 22(3):295-302. PubMed ID: 19959081
[TBL] [Abstract][Full Text] [Related]
4. Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
Penot A; Preux PM; Le Guyader S; Collignon A; Herry A; Dufour V; Monnereau A; Woronoff AS; Troussard X; Pons E; Bordessoule D; Maynadié M
Leuk Lymphoma; 2015 Jun; 56(6):1771-7. PubMed ID: 25535815
[TBL] [Abstract][Full Text] [Related]
5. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
Polednak AP
J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
[TBL] [Abstract][Full Text] [Related]
6. [Descriptive epidemiology of myeloid leukemia].
Matsuo K; Ito H
Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
[TBL] [Abstract][Full Text] [Related]
7. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study.
Rebora P; Czene K; Antolini L; Gambacorti Passerini C; Reilly M; Valsecchi MG
Am J Epidemiol; 2010 Nov; 172(9):1028-33. PubMed ID: 20861143
[TBL] [Abstract][Full Text] [Related]
8. [Clinical epidemiology].
Ohyashiki K
Nihon Rinsho; 2001 Dec; 59(12):2416-20. PubMed ID: 11766349
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological data on chronic myeloid leukemia in Asturias, 1972-1986].
Jonte F; Rayón C; Medina J; García Gala J; García Jalón A; Fanjul E; Morante C; Fresno M; Coma A; Arribas M
Sangre (Barc); 1993 Feb; 38(1):1-4. PubMed ID: 8470030
[TBL] [Abstract][Full Text] [Related]
10. Chronic myeloid leukemia--from the National to the European Registry--limited experience of a single center.
Vlădăreanu AM; Voican I; Bumbea H; Vasile D; Radesi S; Coriu D; Coliţa A; Tălmaci R; Ilea A
Rom J Intern Med; 2010; 48(1):73-9. PubMed ID: 21180244
[TBL] [Abstract][Full Text] [Related]
11. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
Gunnarsson N; Sandin F; Höglund M; Stenke L; Björkholm M; Lambe M; Olsson-Strömberg U; Richter J; Själander A
Eur J Haematol; 2016 Oct; 97(4):387-92. PubMed ID: 26833713
[TBL] [Abstract][Full Text] [Related]
12. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
Hoffmann VS; Baccarani M; Hasford J; Lindoerfer D; Burgstaller S; Sertic D; Costeas P; Mayer J; Indrak K; Everaus H; Koskenvesa P; Guilhot J; Schubert-Fritschle G; Castagnetti F; Di Raimondo F; Lejniece S; Griskevicius L; Thielen N; Sacha T; Hellmann A; Turkina AG; Zaritskey A; Bogdanovic A; Sninska Z; Zupan I; Steegmann JL; Simonsson B; Clark RE; Covelli A; Guidi G; Hehlmann R
Leukemia; 2015 Jun; 29(6):1336-43. PubMed ID: 25783795
[TBL] [Abstract][Full Text] [Related]
13. Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study.
Lauseker M; Gerlach R; Tauscher M; Hasford J
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1441-7. PubMed ID: 27085527
[TBL] [Abstract][Full Text] [Related]
14. Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries.
Mendizabal AM; Garcia-Gonzalez P; Levine PH
Cancer Epidemiol; 2013 Jun; 37(3):247-54. PubMed ID: 23411044
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia.
Bhattacharyya PK
Indian J Pathol Microbiol; 2013; 56(3):188-9. PubMed ID: 24152491
[TBL] [Abstract][Full Text] [Related]
16. Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia.
Mendizabal AM; Younes N; Levine PH
Int J Hematol; 2016 Jan; 103(1):70-8. PubMed ID: 26547571
[TBL] [Abstract][Full Text] [Related]
17. Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538 patients.
Tardieu S; Brun-Strang C; Berthaud P; Michallet M; Guilhot F; Rousselot P; Sambuc R
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):545-53. PubMed ID: 15534856
[TBL] [Abstract][Full Text] [Related]
18. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries.
Silberman G; Crosse MG; Peterson EA; Weston RC; Horowitz MM; Appelbaum FR; Cheson BD
N Engl J Med; 1994 Oct; 331(16):1063-7. PubMed ID: 8090167
[TBL] [Abstract][Full Text] [Related]
19. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
